6533b832fe1ef96bd129ac9f
RESEARCH PRODUCT
IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma
Stephan GrabbeS. BolteSebastian AttigCarmen LoquaiAndreas KuhnJ. UtikalMartin LöwerB-p KlokeC. HuberE. DerhovanessianValesca BukurChristoph HöllerÖ. TüreciA Kemmer BrueckK.h. SchreebChristian AlbrechtA. ParuzynskiM. MillerP. SimonUgur Sahinsubject
0301 basic medicinebusiness.industryMelanomaMutantPhases of clinical researchHematologyFirst in humanmedicine.disease03 medical and health sciences030104 developmental biologyOncologyCancer researchMedicinebusinessyear | journal | country | edition | language |
---|---|---|---|---|
2017-12-01 | Annals of Oncology |